Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042

Prognostic impact of genetic alterations and methylation classes in meningioma

(2022) Anna S. Berghoff et al.   BRAIN PATHOLOGY

A clinically applicable integrative molecular classification of meningiomas

(2021) Farshad Nassiri et al.   NATURE

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

A Molecularly Integrated Grade for Meningioma

(2021) Joseph Driver et al.   NEURO-ONCOLOGY

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

(2021) Sybren L. N. Maas et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)

(2018) Damien C. Weber et al.   RADIOTHERAPY AND ONCOLOGY

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas

(2016) Ganesh M. Shankar et al.   NEURO-ONCOLOGY